Record numbers from Eurostar fail to lift European shares, healthcare heading lower after Novartis reports quarterly incomes below expectations. As Grace Pascoe reports, AkzoNobel, SAP and Ball Corp's 7 billion offer for Britain's Rexam were also the talk of the markets.
